Lobbying disclosures · Lobbying report
BSX: second_quarter 2026 lobbying report
Issues concerning Medicare reimbursement, AI and medical technology. Advocacy concerning tax issues. Advocacy concerning trade issues.
Follow BSX- Became public
- Jul 20, 2026, 11:10 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 7:41 AM EST
Why this is connected
Legal-name match: BOSTON SCIENTIFIC CORPORATION is BOSTON SCIENTIFIC CORP (https://www.sec.gov/Archives/edgar/data/885725/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $80,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/d574df76-2bf6-452b-8dbe-970a59984b6c/","filing_uuid":"d574df76-2bf6-452b-8dbe-970a59984b6c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d574df76-2bf6-452b-8dbe-970a59984b6c/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Adam J. Biegel","dt_posted":"2026-07-20T11:10:26-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"THE ATLANTIC BUILDING","registrant_address_2":"950 F STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":1182,"url":"https://lda.gov/api/v1/registrants/1182/","house_registrant_id":31748,"name":"ALSTON & BIRD LLP","description":"Law Firm","address_1":"THE ATLANTIC BUILDING","address_2":"950 F STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ADAM J. BIEGEL","contact_telephone":"+1 202-239-3692","dt_updated":"2026-07-20T16:02:02.800694-04:00"},"client":{"id":63974,"url":"https://lda.gov/api/v1/clients/63974/","client_id":63974,"name":"BOSTON SCIENTIFIC CORPORATION","general_description":"Innovative medical solutions company.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues concerning Medicare reimbursement, AI and medical technology.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71785,"prefix":null,"prefix_display":null,"first_name":"JANE","nickname":null,"middle_name":null,"last_name":"LUCAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":21262,"prefix":"ms","prefix_display":"MS.","first_name":"MARILYN","nickname":null,"middle_name":"K","last_name":"YAGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10566,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"RAYDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54867,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"SIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146134,"prefix":null,"prefix_display":null,"first_name":"JOSEPH","nickname":null,"middle_name":null,"last_name":"BODDICKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Advocacy concerning tax issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71785,"prefix":null,"prefix_display":null,"first_name":"JANE","nickname":null,"middle_name":null,"last_name":"LUCAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":21262,"prefix":"ms","prefix_display":"MS.","first_name":"MARILYN","nickname":null,"middle_name":"K","last_name":"YAGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10566,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"RAYDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54867,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"SIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146134,"prefix":null,"prefix_display":null,"first_name":"JOSEPH","nickname":null,"middle_name":null,"last_name":"BODDICKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Advocacy concerning trade issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71785,"prefix":null,"prefix_display":null,"first_name":"JANE","nickname":null,"middle_name":null,"last_name":"LUCAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":21262,"prefix":"ms","prefix_display":"MS.","first_name":"MARILYN","nickname":null,"middle_name":"K","last_name":"YAGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10566,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"RAYDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54867,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"SIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146134,"prefix":null,"prefix_display":null,"first_name":"JOSEPH","nickname":null,"middle_name":null,"last_name":"BODDICKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in BSX
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 13, 2026 · disclosed Nov 5, 2026 · Dependent
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 25, 2026$50K–$100K
Rep. Kevin Hern (R-OK-1)
$50K–$100K · Traded Sep 9, 2026 · disclosed Sep 25, 2026 · Joint
Got $6K from the company’s PAC - Sep 25, 2026$50K–$100K
Rep. Kevin Hern (R-OK-1)
Sold (partial) Boston Scientific BSX
$50K–$100K · Traded Sep 4, 2026 · disclosed Sep 25, 2026 · Joint
Got $6K from the company’s PAC - Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Sep 3, 2026 · disclosed Sep 25, 2026 · Dependent
Got $6K from the company’s PAC - Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Sep 3, 2026 · disclosed Sep 25, 2026 · Dependent
Got $6K from the company’s PAC
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.